Skip to main content

Table 1 Baseline characteristics of the study cohort

From: Anthropometric measures and the risk of developing atrial fibrillation: a Swedish Cohort Study

 

Men (n = 9883)

Women (16,078)

Total n:

9883

16,078

Incidence of AF, n (per 1000 p-y)

2102 (11.83)

2215 (6.98)

Age at screening (years)

59 ± 7

57 ± 8

Height (cm)

176.5 ± 6.6

164.7 ± 6.0

Weight (kg)

81.6 ± 12

67.9 ± 11.6

BMI (kg/m2)

26.2 ± 3.4

25.4 ± 4.2

BF %

20.7 ± 5

30.7 ± 5

WHR

0.94 ± 0.06

0.79 ± 0.05

WC (cm)

93.6 ± 12.7

77.7 ± 10.5

WHtR

0.53 ± 0.07

0.48 ± 0.07

Systolic Blood Pressure (mmHg)

144 ± 19

139 ± 20

leukocyte count (10^9/l)

6.37 ± 2.59

6.42 ± 2.32

Follow-up period (years)

18 ± 6.5

19.7 ± 5.3

Apo A1 (mg/dL)

145 ± 24.7

165 ± 27.6

Apo B (mg/dL)

111 ± 25.4

105 ± 26.3

High Alcohol Consumption (> 40/30 g per day for men/women) (%)

7.5

2.4

Current smoking (%)

28.8

27.9

Current use of antihypertensive medicine (%)

17.6

15.30

Use of Lipid Lowering Drugs (%)

3.3

1.80

Immigrated to Sweden (%)

11.9

11.8

Diagnosed diabetes (%)

5.0

3.1

Married (%)

72.7

60.8

Primary school education (%)

45.2

38.9

Secondary school education (%)

19.6

30.5

Higher levels of education (%)

35.2

30.6

History of coronary event (%)

2.9

1.6

History of heart failure (%)

0.4

0.2

  1. Values are means ± standard deviation, unless stated otherwise
  2. p-y person years
  3. AF Atrial Fibrillation, BMI body mass index, BF % bodyfat-percentage, WHR Waist-Hip Ratio, WC Waist Circumference, WHtR Waist-Height Ratio, Apo-A1 apoprotein A1-levels, Apo B apoprotein B-levels